Cover Image
市場調查報告書

橋本病:全球臨床實驗檢討

Hashimoto's Thyroiditis Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 318336
出版日期 內容資訊 英文 58 Pages
訂單完成後即時交付
價格
Back to Top
橋本病:全球臨床實驗檢討 Hashimoto's Thyroiditis Global Clinical Trials Review, H2, 2014
出版日期: 2014年10月31日 內容資訊: 英文 58 Pages
簡介

橋本病(橋本甲狀腺炎)是甲狀腺──即喉結下頸底的小腺體受到免疫系攻擊的狀態。甲狀腺是內分泌系統的一部分,會分泌許多調整身體活動的荷爾蒙。橋本病的發炎,亦稱之為慢性淋巴球性甲狀腺炎,常會造成甲狀腺功能低下。橋本病是美國的甲狀腺機能低下症最大的原因。主要常見於中年婦女,不過男性及各個年齡的女性、兒童也均有可能得病。醫師可透過申狀腺機能檢查來診斷該病。橋本病一般可進行甲狀腺補充療法,簡單且效果兼具。

本報告提供橋本病的治療藥相關臨床實驗調查分析,提供您臨床實驗數及受驗人數,各階段、及Phase狀況,有潛力的企業,正在開發的治療藥資訊,臨床實驗簡介等相關的系統性資訊。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 歐洲的主要國家
    • 北美的主要國家
    • 中東·非洲

G7各國的臨床實驗:免疫系臨床實驗上橋本病所佔的比例

G7各國的臨床實驗:Phase別

G7各國的臨床實驗:各階段

E7各國的臨床實驗:免疫系臨床實驗上橋本病所佔的比例

E7各國的臨床實驗:Phase別

E7各國的臨床實驗:各階段

各方面的臨床實驗

各階段臨床實驗

評估項目別臨床實驗

未完成的臨床實驗

一定期間所採用的實驗對像

贊助商類別臨床實驗

有潛力的贊助商

  • 橋本病的治療藥臨床實驗的主要參與企業

有前途藥物

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Rock Creek Pharmaceuticals INC
    • Cefak KG
  • 主要大學·研究機關·醫院臨床實驗概要
    • National Taiwan University Hospital
    • China Medical University
    • University of Colorado Denver
    • Tabriz University of Medical Sciences
    • The Polish Committee of Scientific Research
    • Taipei Medical University WanFang Hospital
    • Bezm-i Alem Valide Sultan Vakif Gureba Training and Research Hospital
    • Sapienza University of Rome
    • University of Texas Medical Branch at Galveston
    • Ege University

主要的臨床簡介

附錄

圖表

目錄
Product Code: GDHC2381CTIDB

GlobalData's clinical trial report, "Hashimoto's Thyroiditis Global Clinical Trials Review, H2, 2014" provides data on the Hashimoto's Thyroiditis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hashimoto's Thyroiditis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hashimoto's Thyroiditis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Hashimoto's Thyroiditis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Hashimoto's Thyroiditis to Immunology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Hashimoto's Thyroiditis to Immunology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Hashimoto's Thyroiditis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Rock Creek Pharmaceuticals INC
      • Clinical Trial Overview of Rock Creek Pharmaceuticals INC
      • Cefak KG
      • Clinical Trial Overview of Cefak KG
    • Clinical Trial Overview of Top Institutes / Government
      • National Taiwan University Hospital
      • Clinical Trial Overview of National Taiwan University Hospital
      • China Medical University
      • Clinical Trial Overview of China Medical University
      • University of Colorado Denver
      • Clinical Trial Overview of University of Colorado Denver
      • Tabriz University of Medical Sciences
      • Clinical Trial Overview of Tabriz University of Medical Sciences
      • The Polish Committee of Scientific Research
      • Clinical Trial Overview of The Polish Committee of Scientific Research
      • Taipei Medical University WanFang Hospital
      • Clinical Trial Overview of Taipei Medical University WanFang Hospital
      • Bezm-i Alem Valide Sultan Vakif Gureba Training and Research Hospital
      • Clinical Trial Overview of Bezm-i Alem Valide Sultan Vakif Gureba Training and Research Hospital
      • Sapienza University of Rome
      • Clinical Trial Overview of Sapienza University of Rome
      • University of Texas Medical Branch at Galveston
      • Clinical Trial Overview of University of Texas Medical Branch at Galveston
      • Ege University
      • Clinical Trial Overview of Ege University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Hashimoto's Thyroiditis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Hashimoto's Thyroiditis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Hashimoto's Thyroiditis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Hashimoto's Thyroiditis to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Hashimoto's Thyroiditis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Hashimoto's Thyroiditis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Hashimoto's Thyroiditis to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Hashimoto's Thyroiditis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Hashimoto's Thyroiditis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Hashimoto's Thyroiditis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Hashimoto's Thyroiditis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Hashimoto's Thyroiditis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rock Creek Pharmaceuticals INC, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cefak KG, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials Market, Global, Clinical Trials by China Medical University, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado Denver, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tabriz University of Medical Sciences, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials Market, Global, Clinical Trials by The Polish Committee of Scientific Research, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials Market, Global, Clinical Trials by Taipei Medical University WanFang Hospital, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bezm-i Alem Valide Sultan Vakif Gureba Training and Research Hospital, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sapienza University of Rome, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas Medical Branch at Galveston, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ege University, 2014*

List of Figures

  • Hashimoto's Thyroiditis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Hashimoto's Thyroiditis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Hashimoto's Thyroiditis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, Europe, Top Countries (%), 2014*
  • Proportion of Hashimoto's Thyroiditis to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Hashimoto's Thyroiditis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Hashimoto's Thyroiditis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Hashimoto's Thyroiditis to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Hashimoto's Thyroiditis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Hashimoto's Thyroiditis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Hashimoto's Thyroiditis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Hashimoto's Thyroiditis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Hashimoto's Thyroiditis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Hashimoto's Thyroiditis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top